The ease of use and the efficacy of IN glucagon reported in controlled or simulated studies have been confirmed in clinical studies where IN glucagon was administered to T1D adults and caregivers of T1D children to treat acute hypoglycemia episodes at home and in school settings [55,56]. The gene discussed is GCG; the disease is Hypoglycemia.